Huixun Jia

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

Tingyan Shi, Jianqing Zhu, Yanling Feng et al. · The Lancet Oncology · 2021 · 211 citations

Chemotherapy Versus Chemotherapy, Secondary Cytoreduction, Medicine +7

Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer

Lihui Li, Mingsong Wang, Guangyang Yu et al. · JNCI Journal of the National Cancer Institute · 2014 · 183 citations

Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection

Yaqi Li, Huixun Jia, Wencheng Yu et al. · International Journal of Cancer · 2016 · 160 citations · Full text

Prognostic Biomarkers, Surgical Oncology, Gastrointestinal Oncology +15

Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial

Yun Chen, Jinjun Ye, Zhengfei Zhu et al. · Journal of Clinical Oncology · 2019 · 153 citations · Full text

Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer

Dashan Ai, Jinjun Ye, Shihong Wei et al. · JAMA Network Open · 2022 · 69 citations · Full text